Loading clinical trials...
Loading clinical trials...
A Single Site, Phase 2B, Randomized, Double-Blind, Study to Assess the Efficacy, Safety, and Tolerability of Low-Dose Naltrexone and Acetaminophen Combination vs. Placebo in the Treatment of Chronic Low Back Pain (ANODYNE-4)
Conditions
Interventions
Low-dose naltrexone and acetaminophen combination
Placebo
Locations
1
United States
Annette C. Toledano, M.D.
North Miami, Florida, United States
Start Date
August 15, 2017
Primary Completion Date
July 26, 2018
Completion Date
July 26, 2018
Last Updated
April 14, 2021
NCT03836248
NCT05029726
NCT07132762
NCT06419439
NCT06384001
NCT07163117
Lead Sponsor
Allodynic Therapeutics, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions